Lv6
2180 积分 2022-09-21 加入
Epigenetic Drug Discovery
20天前
已关闭
Drug Discovery with Privileged Building Blocks
20天前
已完结
Novel combination therapy targeting oncogenic signaling kinase P21 activated Kinase-1 and chemotherapeutic drugs against triple negative breast cancer
22天前
已完结
Inhibition of PSF activity overcomes resistance to treatment in cancers harboring mutant p53
22天前
已完结
Loss of CDKN2A Enhances the Efficacy of Immunotherapy in EGFR Mutant Non-Small Cell Lung Cancer
22天前
已完结
Tumor Suppressors Condition Differential Responses to the Selective CDK2 Inhibitor BLU-222
22天前
已完结
Emerging Tumor-Agnostic Molecular Targets
22天前
已完结
A small molecule BCL6 inhibitor effectively suppresses diffuse large B cell lymphoma cells growth
22天前
已完结
Co-inhibition of Aurora kinase B and SUV4-20H induces synthetic lethality in Wild-type p53 deficient cancer cells
22天前
已完结
The discovery of a potent PARP1 inhibitor Senaparib
23天前
已完结
皖公网安备34019202002308
